A Pragmatic Trial of Machine Prescription for Migraine

Study acronym: MigPred
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 6 more changesShow less
    • Final enrollment: 160 participants (planned 200)
    • Primary completion date changed from estimate of Dec 31, 2026 to Sep 15, 2026
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised
    • Study description expanded, about 5 words
  2. Minor Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to estimate the ability of ML models to predict the effect of migraine preventives. This will be achieved by first identifying sociodemographic, headache and comorbidity features of migraine patients. Headache days will then be measured for 4 weeks before starting a migraine preventive, and this will be compared to the number of headache days in the first 12 weeks (divided into 28-day periods) after starting treatment. The preventive is regarded as effective if there is a 50% or greater reduction in monthly headache days. After observation of the treatment period, the ML models will use the sociodemographic, headache and comorbidity features, captured before treatment was initiated, to predict treatment effect for all preventives in each participant. These predicted treatment effects will be compared to the actual treatment effects that were observed.
Trial Details
NCT Number NCT06893874
Lead Sponsor Norwegian University of Science and Technology
Conditions
(from sponsor)
Migraine
Related terms Migraine Disorders
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov